SCHEMBL4947675

SCHEMBL4947675

c1nnc(C2CC2)[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13275376 0.89 JAK2 (0.33)
SCHEMBL18814356 0.75 KHK (0.38)
SCHEMBL5648372 0.70 CHRNB2 (0.40)
SCHEMBL4961392 0.69
SCHEMBL12986466 0.65 NT5E (0.35)
SCHEMBL13572996 0.56 KDM4E (0.45)
Amitrole SCHEMBL1187664 0.56
SCHEMBL15748053 0.54
SCHEMBL21449338 0.54 CCR1 (0.30)
SCHEMBL1787799 0.50 PDE10A (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230391760-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO, INC. 2023-12-07 US disclosed
CN-116547279-A Heterocyclic GLP-1 agonists 加舒布鲁姆生物公司 2023-08-04 CN disclosed
WO-2023144160-A1 NEW HETEROCYCLIC COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2023-08-03 WO disclosed
CN-101400660-A Triazole derivative or salt thereof ASTELLAS PHARMA INC (JP) 2009-04-01 CN disclosed
US-20080015234-A1 ADDITIONAL HETEROPOLYCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2008-01-17 US disclosed